{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/72606-054#drug","name":"OMLYCLO","alternateName":"omalizumab-igec","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"72606-054"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761399"}],"activeIngredient":"OMALIZUMAB","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION","manufacturer":{"@type":"Organization","name":"CELLTRION USA, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761399","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-054"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T18:44:18.969Z"}}